Strategies for delivery of faecal occult blood test kits and participation to colorectal cancer screening in the Emilia-Romagna Region of Italy

S. Mancini, Alessandra Ravaioli, Fabio Falcini, Orietta Giuliani, R. Corradini, G. De Girolamo, C. A. Goldoni, A. C. Finarelli, C. Naldoni, P. Landi, P. Sassoli de Bianchi, Lauro Bucchi

Research output: Contribution to journalArticle

Abstract

There is a lack of agreement about which routine invitation strategy should be adopted in colorectal cancer screening. We conducted an observational study to assess the impact of three invitation strategies on participation. Invitation records for the years 2005-2009 were evaluated. There were 2,234,276 invitations from 1,230,683 individuals. Among first invitations, participation associated with direct mailing of the faecal occult blood test kits was slightly lower (relative risk, RR 0.985; 95% confidence interval 0.979-0.990) than that of the reference invitation strategy, that is, the distribution of the test kits by pharmacies. In repeated invitations/previous non-responders, the participation associated with the direct mailing of the test kits was even lower (RR 0.914; 95% confidence interval 0.895-0.933) and this was also the case for the distribution of the test kits by primary care centres (RR 0.983; 95% confidence interval 0.971-0.995). In contrast, in repeated invitations/previous responders, the impact of primary care centres and direct mailing of the test kits was greater than the use of pharmacies, showing only modest RRs: 1.021 (95% confidence interval 1.019-1.023) and 1.029 (95% confidence interval 1.025-1.033) respectively. The faecal occult blood test mailing strategy modestly increased participation in previous responders.

Original languageEnglish
JournalEuropean Journal of Cancer Care
DOIs
Publication statusAccepted/In press - 2016

Fingerprint

Occult Blood
Hematologic Tests
Early Detection of Cancer
Italy
Colorectal Neoplasms
Confidence Intervals
Pharmacies
Primary Health Care
Observational Studies

Keywords

  • Colorectal cancer
  • Participation rate
  • Screening

ASJC Scopus subject areas

  • Oncology

Cite this

Strategies for delivery of faecal occult blood test kits and participation to colorectal cancer screening in the Emilia-Romagna Region of Italy. / Mancini, S.; Ravaioli, Alessandra; Falcini, Fabio; Giuliani, Orietta; Corradini, R.; De Girolamo, G.; Goldoni, C. A.; Finarelli, A. C.; Naldoni, C.; Landi, P.; Sassoli de Bianchi, P.; Bucchi, Lauro.

In: European Journal of Cancer Care, 2016.

Research output: Contribution to journalArticle

@article{25d83f09321a43a399673ddf123e7cbd,
title = "Strategies for delivery of faecal occult blood test kits and participation to colorectal cancer screening in the Emilia-Romagna Region of Italy",
abstract = "There is a lack of agreement about which routine invitation strategy should be adopted in colorectal cancer screening. We conducted an observational study to assess the impact of three invitation strategies on participation. Invitation records for the years 2005-2009 were evaluated. There were 2,234,276 invitations from 1,230,683 individuals. Among first invitations, participation associated with direct mailing of the faecal occult blood test kits was slightly lower (relative risk, RR 0.985; 95{\%} confidence interval 0.979-0.990) than that of the reference invitation strategy, that is, the distribution of the test kits by pharmacies. In repeated invitations/previous non-responders, the participation associated with the direct mailing of the test kits was even lower (RR 0.914; 95{\%} confidence interval 0.895-0.933) and this was also the case for the distribution of the test kits by primary care centres (RR 0.983; 95{\%} confidence interval 0.971-0.995). In contrast, in repeated invitations/previous responders, the impact of primary care centres and direct mailing of the test kits was greater than the use of pharmacies, showing only modest RRs: 1.021 (95{\%} confidence interval 1.019-1.023) and 1.029 (95{\%} confidence interval 1.025-1.033) respectively. The faecal occult blood test mailing strategy modestly increased participation in previous responders.",
keywords = "Colorectal cancer, Participation rate, Screening",
author = "S. Mancini and Alessandra Ravaioli and Fabio Falcini and Orietta Giuliani and R. Corradini and {De Girolamo}, G. and Goldoni, {C. A.} and Finarelli, {A. C.} and C. Naldoni and P. Landi and {Sassoli de Bianchi}, P. and Lauro Bucchi",
year = "2016",
doi = "10.1111/ecc.12631",
language = "English",
journal = "European Journal of Cancer Care",
issn = "0961-5423",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Strategies for delivery of faecal occult blood test kits and participation to colorectal cancer screening in the Emilia-Romagna Region of Italy

AU - Mancini, S.

AU - Ravaioli, Alessandra

AU - Falcini, Fabio

AU - Giuliani, Orietta

AU - Corradini, R.

AU - De Girolamo, G.

AU - Goldoni, C. A.

AU - Finarelli, A. C.

AU - Naldoni, C.

AU - Landi, P.

AU - Sassoli de Bianchi, P.

AU - Bucchi, Lauro

PY - 2016

Y1 - 2016

N2 - There is a lack of agreement about which routine invitation strategy should be adopted in colorectal cancer screening. We conducted an observational study to assess the impact of three invitation strategies on participation. Invitation records for the years 2005-2009 were evaluated. There were 2,234,276 invitations from 1,230,683 individuals. Among first invitations, participation associated with direct mailing of the faecal occult blood test kits was slightly lower (relative risk, RR 0.985; 95% confidence interval 0.979-0.990) than that of the reference invitation strategy, that is, the distribution of the test kits by pharmacies. In repeated invitations/previous non-responders, the participation associated with the direct mailing of the test kits was even lower (RR 0.914; 95% confidence interval 0.895-0.933) and this was also the case for the distribution of the test kits by primary care centres (RR 0.983; 95% confidence interval 0.971-0.995). In contrast, in repeated invitations/previous responders, the impact of primary care centres and direct mailing of the test kits was greater than the use of pharmacies, showing only modest RRs: 1.021 (95% confidence interval 1.019-1.023) and 1.029 (95% confidence interval 1.025-1.033) respectively. The faecal occult blood test mailing strategy modestly increased participation in previous responders.

AB - There is a lack of agreement about which routine invitation strategy should be adopted in colorectal cancer screening. We conducted an observational study to assess the impact of three invitation strategies on participation. Invitation records for the years 2005-2009 were evaluated. There were 2,234,276 invitations from 1,230,683 individuals. Among first invitations, participation associated with direct mailing of the faecal occult blood test kits was slightly lower (relative risk, RR 0.985; 95% confidence interval 0.979-0.990) than that of the reference invitation strategy, that is, the distribution of the test kits by pharmacies. In repeated invitations/previous non-responders, the participation associated with the direct mailing of the test kits was even lower (RR 0.914; 95% confidence interval 0.895-0.933) and this was also the case for the distribution of the test kits by primary care centres (RR 0.983; 95% confidence interval 0.971-0.995). In contrast, in repeated invitations/previous responders, the impact of primary care centres and direct mailing of the test kits was greater than the use of pharmacies, showing only modest RRs: 1.021 (95% confidence interval 1.019-1.023) and 1.029 (95% confidence interval 1.025-1.033) respectively. The faecal occult blood test mailing strategy modestly increased participation in previous responders.

KW - Colorectal cancer

KW - Participation rate

KW - Screening

UR - http://www.scopus.com/inward/record.url?scp=85007494454&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85007494454&partnerID=8YFLogxK

U2 - 10.1111/ecc.12631

DO - 10.1111/ecc.12631

M3 - Article

AN - SCOPUS:85007494454

JO - European Journal of Cancer Care

JF - European Journal of Cancer Care

SN - 0961-5423

ER -